Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.1030
+0.0080 (8.42%)
Aug 22, 2025, 4:00 PM EDT
Vivos Market Cap
Vivos has a market cap or net worth of $46.74 million as of August 22, 2025. Its market cap has decreased by -0.37% in one year.
Market Cap
46.74M
Enterprise Value
53.43M
Revenue
51.74K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 46.74M, an increase of 286.84%. That is a compound annual growth rate of 5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 46.74M | -7.38% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | 30.61M | 348.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |